
Home » GSK Drug Halves Attacks in Hard-to-Treat Asthma
GSK Drug Halves Attacks in Hard-to-Treat Asthma
August 17, 2012
An experimental drug for treating severe asthma from GlaxoSmithKline nearly halved the number of attacks suffered by patients with a hard-to-treat form of the disease in a clinical study, boosting hopes for its commercial success.
Reuters
Reuters
Upcoming Events
-
26Jan
-
27Jan
-
27Jan
-
09Feb
-
10Feb
-
11Feb